Kyprolis 60mg Injection

By Kyprolis

Rx

1 Injection in a Vial

Composition icon

Composition

Carfilzomib(60mg)

Manufacturer - Dr Reddy's Laboratories Ltd icon

Manufacturer - Dr Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Expires on or after icon

Expires on or after

July, 2025

About Kyprolis 60mg Injection

Kyprolis 60mg Injection is a medication primarily used in the treatment of multiple myeloma, a type of cancer. It works by halting or slowing down the growth of cancer cells within the body. The medication is administered through an injection by a qualified healthcare professional. The dosage and frequency of administration will be determined by your doctor based on your specific condition, and may be adjusted as needed throughout your treatment.

It is crucial to strictly follow your doctor's instructions regarding the administration of Kyprolis 60mg Injection, as improper use or taking too much of the medication can result in severe side effects. While the benefits of the medication may not be immediately noticeable, it is important to continue taking it as prescribed unless directed otherwise by your healthcare provider.

Common side effects of Kyprolis 60mg Injection may include fatigue, nausea, and fever. This medication can also lower the levels of blood cells in your system, increasing the risk of infections. If you experience symptoms such as fever, chills, muscle or joint pain, facial swelling, or chest pain, it is important to promptly inform your doctor. Staying well-hydrated by drinking plenty of fluids is recommended while undergoing treatment with this medication.

Prior to taking Kyprolis 60mg Injection, inform your doctor about any pre-existing conditions such as heart disease, liver or kidney problems, as well as any ongoing treatment with other medications for infections. It is essential to disclose all medications you are currently using as there may be interactions with Kyprolis. This medication is not advised during pregnancy or while breastfeeding, and both males and females should practice effective contraception throughout the treatment period to prevent pregnancy.


Benefits

Kyprolis 60mg Injection, containing Carfilzomib as its active ingredient, is a crucial treatment option for individuals diagnosed with multiple myeloma. This condition involves the body's accelerated bone destruction, leading to weakened and painful bones that are prone to fractures. When used in combination with other cancer therapies such as chemotherapy, Kyprolis 60mg Injection plays a vital role in the treatment regimen.

One of the primary benefits of Kyprolis 60mg Injection is its ability to target and kill cancerous cells while also impeding their further growth and spread to other areas of the body. By suppressing proteasomes within the multiple myeloma cells, Carfilzomib, the key component of this medication, effectively hinders protein breakdown, resulting in the accumulation of proteins within the malignant cells. This build-up ultimately leads to the destruction of these harmful cells, thereby contributing to the treatment of multiple myeloma.

Moreover, incorporating Kyprolis 60mg Injection into the treatment plan has been shown to increase the survival rate of individuals battling multiple myeloma. It not only addresses the existing cancer cells but also works preventatively to inhibit their proliferation, offering patients a chance at improved outcomes and quality of life.

To maximize the benefits of Kyprolis 60mg Injection, it is imperative to adhere closely to your healthcare provider's recommendations and follow the prescribed dosage regimen diligently. Additionally, your doctor may suggest supplements of calcium and Vitamin D3 if needed to maintain optimal levels of these essential nutrients, especially if you do not have high blood calcium levels.

In conclusion, Kyprolis 60mg Injection stands out as a valuable weapon in the fight against multiple myeloma, offering tangible benefits such as tumor cell destruction, growth inhibition, increased survival rates, and overall improvement in the management of this challenging condition.


How to use the Kyprolis 60mg Injection

When it comes to using Kyprolis 60mg Injection, it's important to remember that this medicine should only be given by your doctor or nurse. It is not safe to try and give it to yourself. Carfilnat 60Mg Inj is usually given in a hospital under the watchful eye of a doctor who is specially trained to give anticancer medications. So, it's crucial to follow your doctor's guidance and not attempt to administer Kyprolis 60mg Injection on your own. Trust your healthcare provider to handle the injection properly for your safety and well-being.


Uses of Kyprolis 60mg Injection

Carfilzomib injection, also known as Kyprolis 60mg Injection, is used in the treatment of a type of cancer called multiple myeloma. Multiple myeloma is a cancer that affects plasma cells, which are a type of white blood cell. Carfilzomib works by blocking certain proteins in the body that can help cancer cells grow and survive. It is typically used in patients who have already tried other treatments that were not successful or stopped working. Carfilzomib injection is administered by a healthcare provider through intravenous infusion. This medication plays an important role in slowing down the progression of multiple myeloma and improving the overall quality of life for patients with this condition.


What conditions Kyprolis 60mg Injection treats?

Kyprolis 60mg Injection is used for treating myeloma, a type of cancer that affects plasma cells in the bone marrow. These plasma cells, which normally produce infection-fighting antibodies, grow excessively in myeloma, displacing normal cells responsible for producing essential blood components. Myeloma, also known as multiple myeloma, is the frequent form of plasma cell tumor that originates in the bone marrow and has the potential to spread widely within the body.


Should you consult a doctor?

If you experience fever, chills, joint or muscle pain, flushing or swelling of the face, or chest pain while taking Kyprolis 60mg Injection, it is important to consult your doctor. These symptoms could indicate a decrease in blood cells, leading to increased susceptibility to infections. Additionally, if you have heart disease, liver or kidney issues, or are on medications for infections, inform your doctor before starting this treatment. Since this medication can interact with other drugs, it is crucial to share a complete list of all medications you are taking with your healthcare provider. Furthermore, Kyprolis 60mg Injection is not recommended during pregnancy or breastfeeding, and the use of effective contraception is vital to prevent pregnancy while on this treatment. Always follow your doctor's guidelines on dosage and administration to avoid serious side effects and ensure maximum benefits.


Side effects of Kyprolis 60mg Injection

When you receive Kyprolis 60mg Injection, you may experience some side effects. Most of these side effects are mild and go away as your body gets used to the medication. However, if they persist or if you are concerned about them, it's important to consult your doctor. Some common side effects of Kyprolis 60mg Injection include fatigue, which can make you feel overtired, anemia, which is a lack of red blood cells in the body, nausea, and low blood platelets. You may also experience symptoms such as fever, shortness of breath, diarrhea, and an increased risk of infection. Other potential side effects include feeling breathless and looking pale, bruising easily, bleeding gums or nosebleeds, low potassium levels in the blood, decreased appetite, difficulty sleeping (insomnia), headaches, dizziness, numbness or tingling in the hands and feet, high blood pressure, coughing, constipation, feeling sick or vomiting, abdominal pain, and joint, muscle, or bone pain. It's important to be aware of these possible side effects and discuss any concerns with your healthcare provider.


Safety advice

scroll

liver

When using Kyprolis 60mg Injection, it is important to exercise caution if you have liver disease. It may be necessary to adjust the dose of Kyprolis 60mg Injection for patients with liver issues. It is advisable to consult your doctor regarding the appropriate usage of the injection in such cases.

scroll

kidney

Kyprolis 60mg Injection requires caution in patients with kidney disease. Dose adjustment may be necessary. Kindly consult your doctor.

scroll

alcohol

The safety of drinking alcohol with Kyprolis 60mg Injection is unknown. It is advisable to consult your doctor before combining the two.

scroll

driving

It is important to avoid driving if you experience decreased alertness, vision changes, sleepiness, or dizziness while using Kyprolis 60mg Injection.

scroll

pregnancy

Kyprolis 60mg Injection is not safe to use during pregnancy as it can harm the developing baby. In rare life-threatening situations, a doctor may prescribe it if the benefits outweigh the risks. Always consult your doctor before using Kyprolis 60mg Injection during pregnancy.

scroll

breastfeeding

Kyprolis 60mg Injection is not recommended for use during breastfeeding as it may lead to potential harm to the baby due to possible toxicity.


Consumption warning before consuming Kyprolis 60mg Injection

Before using Carfilnat 60Mg Injection, it is crucial to disclose your medical background and current medications to your doctor to ensure safety. Refrain from using Carfilnat 60Mg Injection if pregnant, breastfeeding, or allergic to any of its components. Both men and women using Carfilnat 60Mg Injection should employ birth control methods to prevent pregnancy. Alert your doctor immediately if pregnancy occurs during treatment. Notify your doctor of any history of heart failure, ischemia, or other conditions like pulmonary hypertension or thrombocytopenia for close monitoring. Serious reactions may arise within 24 hours post-injection; you will receive pre-treatment medication to reduce this risk. Contact your doctor promptly if you experience symptoms such as fever, chills, muscle pain, swelling, vomiting, weakness, or breathing difficulties after administration of Carfilnat 60Mg Injection.


Disease interactions

Carfilnat 60Mg Inj interacts with several disease conditions. Patients with tumour lysis syndrome, a condition where cancer cells die rapidly and release their contents into the blood, should use Kyprolis 60mg Injection with caution. It may also affect patients with heart disease, pulmonary impairment, bleeding disorders, and low or high blood pressure. Additionally, individuals with renal or hepatic impairment should be careful when using this medication. Patients with infections caused by bacteria, fungi, protozoa, or viruses should also be cautious when considering the use of Kyprolis 60mg Injection.


Related lab tests

When you are receiving Kyprolis 60mg Injection, your healthcare provider may order certain lab tests to monitor your health. These lab tests can help them understand how your body is responding to the medication. The following are the related lab tests that are commonly done in association with Kyprolis 60mg Injection:

1. Albumin/Globulin Ratio, Serum: This test measures the ratio of two proteins in your blood, albumin and globulin. It can provide information about your overall health and liver function.

2. Calcium: This test measures the levels of calcium in your blood. Kyprolis 60mg Injection may affect calcium levels in your body, so this test can help monitor and adjust your treatment as needed.

3. Complete Blood Count: This test provides important information about your red and white blood cell counts, as well as your platelet count. It can help detect any potential side effects or complications from Kyprolis 60mg Injection.

4. Kidney Function Test: This test evaluates how well your kidneys are functioning. Kyprolis 60mg Injection can impact kidney function, so this test is important for monitoring any changes and ensuring your kidneys are working properly.

These lab tests are crucial for ensuring your safety and well-being while undergoing treatment with Kyprolis 60mg Injection. Your healthcare provider will interpret the results of these tests and make any necessary adjustments to your treatment plan.


Additional Information

Habit FormingNo
Chemical ClassEpoxomicin Derivate
Therapeutic Class-
Action ClassProteasome inhibitor

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

47325

Inclusive of all taxes

Content verified by

chevron-right

Dr. Mansi Chaudhari

MBBS - General Medicine

Last update on 11-Feb-2025